Calida, Baby Boy .

HRN: 29-45-09  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/08/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/08/2026
08/15/2026
IV
54mg
Q24h
Neonatal Sepsis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: